Advanced

(90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3)

Kolstad, Arne; Laurell, Anna; Andersen, Niels S.; Elonen, Erkki; Raty, Riikka; Pedersen, Lone Bredo; Loft, Annika; Bogsrud, Trond Velde; Nordstrom, Marie and Gillstrom, Dorte, et al. (2009) 51st Annual Meeting of the American-Society-of-Hematology In Blood 114(22). p.384-384
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
114
issue
22
pages
384 - 384
publisher
American Society of Hematology
conference name
51st Annual Meeting of the American-Society-of-Hematology
external identifiers
  • wos:000272725801112
ISSN
1528-0020
language
English
LU publication?
yes
id
31dcaf48-96ac-428a-ac07-7e713431f93f (old id 1616252)
date added to LUP
2010-06-23 10:01:32
date last changed
2016-04-15 19:11:21
@misc{31dcaf48-96ac-428a-ac07-7e713431f93f,
  author       = {Kolstad, Arne and Laurell, Anna and Andersen, Niels S. and Elonen, Erkki and Raty, Riikka and Pedersen, Lone Bredo and Loft, Annika and Bogsrud, Trond Velde and Nordstrom, Marie and Gillstrom, Dorte and Hansen, Per Boye and Bentzen, Hans and Fagerli, Unn-Merete and Meyer, Peter and Nilsson-Ehle, Herman and Jerkeman, Mats and Lehmann, Anne Kristine and Lauritzsen, Grete F. and Sundstrom, Christer and Delabie, Jan and Karjalainen-Lindsberg, Marja-Liisa and Ralfkiaer, Elisabeth and Ehinger, Mats and Geisler, Christian H.},
  issn         = {1528-0020},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {22},
  pages        = {384--384},
  publisher    = {American Society of Hematology},
  series       = {Blood},
  title        = {(90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3)},
  volume       = {114},
  year         = {2009},
}